Open AccessProof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia
Author(s) -
Christine E. Marx,
Richard S.E. Keefe,
Robert W. Buchanan,
Robert M. Hamer,
Jason D. Kilts,
Daniel W. Bradford,
Jennifer L. Strauss,
Jennifer C. Naylor,
Victoria Payne,
Jeffrey A. Lieberman,
Adam Savitz,
Linda A. Leimone,
Lawrence H. Dunn,
Patrizia Porcu,
A. Leslie Morrow,
Lawrence J. Shampine
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7268-fx30
Subject(s) - pregnenolone , neuroactive steroid , schizophrenia (object oriented programming) , proof of concept , cognition , psychology , neuroscience , clinical psychology , psychotherapist , psychiatry , medicine , computer science , receptor , steroid , hormone , gabaa receptor , operating system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom